Literature DB >> 21732814

Isolation and characterization of human anterior cruciate ligament-derived vascular stem cells.

Tomoyuki Matsumoto1, Sheila M Ingham, Yutaka Mifune, Aki Osawa, Alison Logar, Arvydas Usas, Ryosuke Kuroda, Masahiro Kurosaka, Freddie H Fu, Johnny Huard.   

Abstract

The anterior cruciate ligament (ACL) usually fails to heal after rupture mainly due to the inability of the cells within the ACL tissue to establish an adequate healing process, making graft reconstruction surgery a necessity. However, some reports have shown that there is a healing potential of ACL with primary suture repair. Although some reports showed the existence of mesenchymal stem cell-like cells in human ACL tissues, their origin still remains unclear. Recently, blood vessels have been reported to represent a rich supply of stem/progenitor cells with a characteristic expression of CD34 and CD146. In this study, we attempted to validate the hypothesis that CD34- and CD146-expressing vascular cells exist in hACL tissues, have a potential for multi-lineage differentiation, and are recruited to the rupture site to participate in the intrinsic healing of injured ACL. Immunohistochemistry and flow cytometry analysis of hACL tissues demonstrated that it contains significantly more CD34 and CD146-positive cells in the ACL ruptured site compared with the noninjured midsubstance. CD34+CD45- cells isolated from ACL ruptured site showed higher expansionary potentials than CD146+CD45- and CD34-CD146-CD45- cells, and displayed higher differentiation potentials into osteogenic, adipogenic, and angiogenic lineages than the other cell populations. Immunohistochemistry of fetal and adult hACL tissues demonstrated a higher number of CD34 and CD146-positive cells in the ACL septum region compared with the midsubstance. In conclusion, our findings suggest that the ACL septum region contains a population of vascular-derived stem cells that may contribute to ligament regeneration and repair at the site of rupture. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732814      PMCID: PMC3871494          DOI: 10.1089/scd.2010.0528

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  60 in total

Review 1.  The vascular wall as a source of stem cells.

Authors:  Manuela Tavian; Bo Zheng; Estelle Oberlin; Mihaela Crisan; Bin Sun; Johnny Huard; Bruno Peault
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 2.  Anatomy of the anterior cruciate ligament.

Authors:  V B Duthon; C Barea; S Abrassart; J H Fasel; D Fritschy; J Ménétrey
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-10-19       Impact factor: 4.342

Review 3.  Tissue engineering for anterior cruciate ligament reconstruction: a review of current strategies.

Authors:  Frank A Petrigliano; David R McAllister; Benjamin M Wu
Journal:  Arthroscopy       Date:  2006-04       Impact factor: 4.772

4.  Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL.

Authors:  Martha M Murray; Kurt P Spindler; Clint Devin; Brian S Snyder; John Muller; Masaya Takahashi; Percy Ballard; Lillian B Nanney; David Zurakowski
Journal:  J Orthop Res       Date:  2006-04       Impact factor: 3.494

5.  Vascular wall resident progenitor cells: a source for postnatal vasculogenesis.

Authors:  Elvin Zengin; Fariba Chalajour; Ursula M Gehling; Wulf D Ito; Hendrik Treede; Heidrun Lauke; Joachim Weil; Hermann Reichenspurner; Nerbil Kilic; Süleyman Ergün
Journal:  Development       Date:  2006-03-08       Impact factor: 6.868

6.  Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo.

Authors:  Bo Zheng; Baohong Cao; Guangheng Li; Johnny Huard
Journal:  Tissue Eng       Date:  2006-07

7.  Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration.

Authors:  Muhammad Agung; Mitsuo Ochi; Shinobu Yanada; Nobuo Adachi; Yasunori Izuta; Takuma Yamasaki; Katsuhiro Toda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-06-20       Impact factor: 4.342

8.  Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing.

Authors:  Tomoyuki Matsumoto; Atsuhiko Kawamoto; Ryosuke Kuroda; Masakazu Ishikawa; Yutaka Mifune; Hiroto Iwasaki; Masahiko Miwa; Miki Horii; Saeko Hayashi; Akira Oyamada; Hiromi Nishimura; Satoshi Murasawa; Minoru Doita; Masahiro Kurosaka; Takayuki Asahara
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

9.  Effects of local administration of vascular endothelial growth factor on mechanical characteristics of the semitendinosus tendon graft after anterior cruciate ligament reconstruction in sheep.

Authors:  Toshikazu Yoshikawa; Harukazu Tohyama; Taro Katsura; Eiji Kondo; Yoshihisa Kotani; Hideo Matsumoto; Yoshiaki Toyama; Kazunori Yasuda
Journal:  Am J Sports Med       Date:  2006-11-07       Impact factor: 6.202

10.  A sixteen-year follow-up of three operative techniques for the treatment of acute ruptures of the anterior cruciate ligament.

Authors:  Jon Olav Drogset; Torbjørn Grøntvedt; Ole Rasmus Robak; Anders Mølster; Annja T Viset; Lars Engebretsen
Journal:  J Bone Joint Surg Am       Date:  2006-05       Impact factor: 5.284

View more
  26 in total

1.  An emerging cell-based strategy in orthopaedics: endothelial progenitor cells.

Authors:  Kivanc Atesok; Tomoyuki Matsumoto; Jon Karlsson; Takayuki Asahara; Anthony Atala; M Nedim Doral; Rene Verdonk; Ru Li; Emil Schemitsch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-09       Impact factor: 4.342

2.  Post injury changes in the properties of mesenchymal stem cells derived from human anterior cruciate ligaments.

Authors:  Shuya Nohmi; Yuji Yamamoto; Hiroki Mizukami; Yasuyuki Ishibashi; Eiichi Tsuda; Keiichiro Maniwa; Soroku Yagihashi; Shigeru Motomura; Satoshi Toh; Ken-Ichi Furukawa
Journal:  Int Orthop       Date:  2012-07       Impact factor: 3.075

3.  Intraligamentous synovial chondromatosis of the anterior cruciate ligament.

Authors:  Aria Ashir; Wei-Xian Li; Hoda Shirazian; Douglas G Chang; Eric Y Chang
Journal:  Skeletal Radiol       Date:  2019-11-23       Impact factor: 2.199

4.  Harnessing endogenous stem/progenitor cells for tendon regeneration.

Authors:  Chang H Lee; Francis Y Lee; Solaiman Tarafder; Kristy Kao; Yena Jun; Guodong Yang; Jeremy J Mao
Journal:  J Clin Invest       Date:  2015-06-08       Impact factor: 14.808

5.  Perivascular-derived stem cells with neural crest characteristics are involved in tendon repair.

Authors:  Wei Xu; Yanjun Sun; Jinye Zhang; Kang Xu; Lianhong Pan; Long He; Yang Song; Lucy Njunge; Zhiling Xu; Martin Y M Chiang; Kuo-Li Paul Sung; Cheng Ming Chuong; Li Yang
Journal:  Stem Cells Dev       Date:  2015-01-19       Impact factor: 3.272

6.  Anterior Cruciate Ligament Reconstruction and Preservation: The Single-Anteromedial Bundle Biological Augmentation (SAMBBA) Technique.

Authors:  Bertrand Sonnery-Cottet; Benjamin Freychet; Colin G Murphy; Barbara H B Pupim; Mathieu Thaunat
Journal:  Arthrosc Tech       Date:  2014-11-24

7.  Bioethics in practice: a quarterly column about medical ethics: stem cell ethics.

Authors:  Deryk Jones
Journal:  Ochsner J       Date:  2013

Review 8.  Anatomic anterior cruciate ligament reconstruction: a changing paradigm.

Authors:  Freddie H Fu; Carola F van Eck; Scott Tashman; James J Irrgang; Morey S Moreland
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-08-03       Impact factor: 4.342

Review 9.  Cellular therapy in bone-tendon interface regeneration.

Authors:  Benjamin B Rothrauff; Rocky S Tuan
Journal:  Organogenesis       Date:  2013-12-09       Impact factor: 2.500

Review 10.  Is CD34 truly a negative marker for mesenchymal stromal cells?

Authors:  Ching-Shwun Lin; Hongxiu Ning; Guiting Lin; Tom F Lue
Journal:  Cytotherapy       Date:  2012-11       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.